{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:11:09Z","timestamp":1794744669503,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002749","name":"Belgian Federal Science Policy Office","doi-asserted-by":"publisher","award":["DR\/91\/BENZOCARE"],"award-info":[{"award-number":["DR\/91\/BENZOCARE"]}],"id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002749","name":"Belgian Federal Science Policy Office","doi-asserted-by":"publisher","award":["DR\/91\/BENZOCARE"],"award-info":[{"award-number":["DR\/91\/BENZOCARE"]}],"id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002749","name":"Belgian Federal Science Policy Office","doi-asserted-by":"publisher","award":["DR\/91\/BENZOCARE"],"award-info":[{"award-number":["DR\/91\/BENZOCARE"]}],"id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The long-term use of benzodiazepine receptor agonists (BZRAs) poses a significant public health challenge in Belgium because of the associated risks of physical and psychological dependence. Despite guidelines recommending short-term use, BZRAs are frequently prescribed beyond the recommended duration, leading to chronic use and associated harm. To address this issue, a policy Delphi study was conducted to assess targeted strategies for preventing long-term BZRA use through the lenses of primary, secondary, and tertiary prevention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study involved a panel of experts, including healthcare professionals and patients, who participated in two rounds of questionnaires to evaluate 27 policy recommendations. These recommendations were assessed for feasibility, support, and importance, and participants were also asked whether the necessary conditions were in place to implement each recommendation. This approach aimed to identify areas of consensus and divergence among participants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Key findings reveal a strong consensus on the need for awareness campaigns aimed at healthcare professionals and the general public to highlight the risks associated with BZRA withdrawal. There was also significant support for implementing training programs to equip healthcare providers with the skills needed to manage BZRA withdrawal effectively. However, some recommendations, such as increasing remuneration for long follow-up consultations and establishing a peer support \"benzo-buddy\" system, garnered less agreement, suggesting that these proposals require further refinement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study highlights the complexity of addressing long-term BZRA use and advocates for a comprehensive, multifaceted approach. This approach should integrate education, awareness, and tailored healthcare practices to increase prevention efforts. The findings emphasise the importance of coordinated interventions across different levels of prevention to effectively mitigate long-term use on BZRAs in Belgium.<\/jats:p>\n            <jats:p>By refining and implementing these strategies, the likelihood of achieving meaningful improvements in the management and reduction of chronic BZRA use could be significantly increased, contributing to better public health outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13690-025-01580-w","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T07:03:29Z","timestamp":1750662209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary, secondary and tertiary prevention of long-term benzodiazepine receptor agonists use in Belgium: a policy Delphi"],"prefix":"10.1186","volume":"83","author":[{"given":"Pauline","family":"Van Ngoc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Scholtes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Belche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Ceuterick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"1580_CR1","doi-asserted-by":"publisher","first-page":"S399","DOI":"10.1016\/S0924-977X(99)00051-6","volume":"9","author":"M Lader","year":"1999","unstructured":"Lader M. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol. 1999;9:S399.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"12","key":"1580_CR2","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"M Lader","year":"2011","unstructured":"Lader M. Benzodiazepines revisited-will we ever learn? Addiction. 2011;106(12):2086\u2013109.","journal-title":"Addiction"},{"issue":"2","key":"1580_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","volume":"77","author":"M Lader","year":"2014","unstructured":"Lader M. Benzodiazepine harm: how can it be reduced? Bri J Clin Pharmacol. 2014;77(2):295\u2013301.","journal-title":"Bri J Clin Pharmacol"},{"key":"1580_CR4","unstructured":"Centre Belge d\u2019Informations Pharmacoth\u00e9rapeutique C. Hypnotiques, s\u00e9datifs, anxiolitiques. Available from: https:\/\/www.cbip.be\/fr\/chapters\/11?frag=7476"},{"key":"1580_CR5","unstructured":"Kiridis S, Sawchik J, Maenhaut N, Sabbe M, Wuillaume F, Hamdani J. Survey on the use of benzodiazepines and Z-drugs to treat insomnia in Belgium. Federal Agency for Medicines and Health Products; 2022. Available from: https:\/\/www.fagg.be\/sites\/default\/files\/BZRA_study_report_2020_DEF_21.06.2022_0.pdf"},{"key":"1580_CR6","volume-title":"Preventive Medicine for the Doctor in His Community: An Epidemiologic Approach","author":"HR Leavell","year":"1953","unstructured":"Leavell HR, Clark EG. Preventive Medicine for the Doctor in His Community: An Epidemiologic Approach. New York: McGraw-Hill; 1953."},{"key":"1580_CR7","unstructured":"Institut national d\u2019assurance maladie-invalidit\u00e9. Honoraires, prix et remboursements - Programme de sevrage aux benzodiaz\u00e9pines et produits apparent\u00e9s (Z-drug). Available from: https:\/\/www.inami.fgov.be\/fr\/theme\/honoraires-prix-et-remboursements-programme-de-sevrage-aux-benzodiazepines-et-produits-apparentes-z-drug"},{"key":"1580_CR8","unstructured":"Centre Belge d\u2019Informations Pharmacoth\u00e9rapeutique. Lancement d\u2019un programme de sevrage progressif des benzodiaz\u00e9pines et apparent\u00e9s. 2023. Available from: https:\/\/www.cbip.be\/fr\/lancement-dun-programme-de-sevrage-progressif-des-benzodiazepines-et-apparentes\/"},{"key":"1580_CR9","unstructured":"Service Public F\u00e9d\u00e9ral. \u00ab\u202fSomnif\u00e8res et calmants, pensez d\u2019abord aux autres solutions\u202f\u00bb. 2018. Available from: https:\/\/www.health.belgium.be\/fr\/sante\/prenez-soin-de-vous\/medication\/somniferes-et-calmants"},{"issue":"12","key":"1580_CR10","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.4236\/health.2017.912124","volume":"09","author":"M Ranjbar","year":"2017","unstructured":"Ranjbar M, Aslanpour Z, Kostrzewski A, Cooke AD. Public health campaigns and medicine use awareness: a systematic literature review. Health. 2017;09(12):1689\u2013710.","journal-title":"Health"},{"issue":"7","key":"1580_CR11","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/jac\/dkq126","volume":"65","author":"CAM McNulty","year":"2010","unstructured":"McNulty CAM, Nichols T, Boyle PJ, Woodhead M, Davey P. The English antibiotic awareness campaigns: did they change the public\u2019s knowledge of and attitudes to antibiotic use? J Antimicrob Chemother. 2010;65(7):1526\u201333.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1580_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s10461-012-0295-x","volume":"17","author":"TP Giordano","year":"2013","unstructured":"Giordano TP, Rodriguez S, Zhang H, Kallen MA, Jibaja-Weiss M, Buscher AL, et al. Effect of a clinic-wide social marketing campaign to improve adherence to antiretroviral therapy for HIV infection. AIDS Behav. 2013;17(1):104\u201312.","journal-title":"AIDS Behav"},{"issue":"1","key":"1580_CR13","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1186\/s12889-022-14885-0","volume":"22","author":"A Ghahramani","year":"2022","unstructured":"Ghahramani A, De Courten M, Prokofieva M. The potential of social media in health promotion beyond creating awareness: an integrative review. BMC Public Health. 2022;22(1):2402.","journal-title":"BMC Public Health"},{"key":"1580_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.techfore.2015.12.009","volume":"104","author":"RC de Lo\u00eb","year":"2016","unstructured":"de Lo\u00eb RC, Melnychuk N, Murray D, Plummer R. Advancing the state of policy delphi practice: a systematic review evaluating methodological evolution, innovation, and opportunities. Technol Forecast Social Change. 2016;104:78\u201388.","journal-title":"Technol Forecast Social Change"},{"key":"1580_CR15","unstructured":"Dusi D, Stevens P. Thematic analysis\u202f: an analytical method in its own right. In: Qualitative data analysis: key approaches. London: SAGE; 2022. p. 293\u2013316."},{"key":"1580_CR16","doi-asserted-by":"publisher","unstructured":"Chyung SY, Kennedy M, Campbell I. Evidence-based survey design: The use of ascending or descending order of likert-type response options. Perform Improve. 2018;57:9\u201316.\u00a0https:\/\/doi.org\/10.1002\/pfi.21800.","DOI":"10.1002\/pfi.21800"},{"issue":"2","key":"1580_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0040-1625(70)90161-7","volume":"2","author":"M Turoff","year":"1970","unstructured":"Turoff M. The design of a policy Delphi. Technol Forecast Social Change. 1970;2(2):149\u201371.","journal-title":"Technol Forecast Social Change"},{"issue":"3","key":"1580_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7748\/nr2014.01.21.3.32.e342","volume":"21","author":"P Meskell","year":"2014","unstructured":"Meskell P, Murphy K, Shaw D, Casey D. Insights into the use and complexities of the Policy Delphi technique. Nurse Res. 2014;21(3):32\u20139.","journal-title":"Nurse Res"},{"issue":"5","key":"1580_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1365-2710.2005.00674.x","volume":"30","author":"WB Dollman","year":"2005","unstructured":"Dollman WB, LeBlanc VT, Stevens L, O\u2019Connor PJ, Roughead EE, Gilbert AL. Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach. J Clin Pharm Ther. 2005;30(5):425\u201332.","journal-title":"J Clin Pharm Ther"},{"key":"1580_CR20","unstructured":"Choosing Wisely (Australia). Choosing Wisely (Australia). Available from: https:\/\/www.choosingwisely.org.au\/recommendations\/racgp5 .Cited 2025 Feb 12"},{"key":"1580_CR21","unstructured":"Choosing Wisely (Italia). Choosing Wisely (Italia). Available from: https:\/\/choosingwiselyitaly.org\/en\/raccomandazione-prof\/dont-use-benzodiazepines-or-other-sedative-hypnotics-in-older-adults-as-first-choice-for-insomnia\/ .Cited 2025 Feb 12"},{"key":"1580_CR22","unstructured":"Choosing Wisely (Canada). Choosing Wisely (Canada). Available from: https:\/\/choosingwiselycanada.org\/recommendation\/geriatrics\/ .Cited 2025 Feb 12"},{"issue":"2","key":"1580_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/bmjqs-2014-003821","volume":"24","author":"W Levinson","year":"2015","unstructured":"Levinson W, Kallewaard M, Bhatia RS, Wolfson D, Shortt S, Kerr EA. \u2018Choosing Wisely\u2019: a growing international campaign. BMJ Qual Saf. 2015;24(2):167\u201374.","journal-title":"BMJ Qual Saf"},{"issue":"3","key":"1580_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pec.2006.08.011","volume":"65","author":"MF Wen","year":"2007","unstructured":"Wen MF, Lin SJ, Yang YHK, Huang YM, Wang HP, Chen CS, et al. Effects of a national medication education program in Taiwan to change the public\u2019s perceptions of the roles and functions of pharmacists. Pat Educ Counsel. 2007;65(3):303\u201310.","journal-title":"Pat Educ Counsel"},{"issue":"3","key":"1580_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.gerinurse.2006.03.015","volume":"27","author":"Q Shen","year":"2006","unstructured":"Shen Q, Karr M, Ko A, Chan DKY, Khan R, Duvall D. Evaluation of a medication education program for elderly hospital in-patients. Geriatr Nurs. 2006;27(3):184\u201392.","journal-title":"Geriatr Nurs"},{"issue":"6","key":"1580_CR26","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.sapharm.2015.11.003","volume":"12","author":"V Gupta","year":"2016","unstructured":"Gupta V, Hincapie AL, Frausto S, Bhutada NS. Impact of a web-based intervention on the awareness of medication adherence. Res Social Adm Pharm. 2016;12(6):926\u201336.","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"1580_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1345\/aph.1G312","volume":"40","author":"YM Huang","year":"2006","unstructured":"Huang YM, Wang HP, Yang YHK, Lin SJ, Lin HW, Chen CS, et al. Effects of a National Health Education Program on the Medication Knowledge of the Public in Taiwan. Ann Pharmacother. 2006;40(1):102\u20138.","journal-title":"Ann Pharmacother"},{"issue":"9748","key":"1580_CR28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0140-6736(10)60809-4","volume":"376","author":"MA Wakefield","year":"2010","unstructured":"Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. The Lancet. 2010;376(9748):1261\u201371.","journal-title":"The Lancet"},{"issue":"1","key":"1580_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13011-020-00288-0","volume":"15","author":"J Zwick","year":"2020","unstructured":"Zwick J, Appleseth H, Arndt S. Stigma: how it affects the substance use disorder patient. Subst Abuse Treat Prev Policy. 2020;15(1):50 s13011\u2013020\u201300288\u20130.","journal-title":"Subst Abuse Treat Prev Policy."},{"issue":"7","key":"1580_CR30","first-page":"1200","volume":"53","author":"S Anthierens","year":"2007","unstructured":"Anthierens S, Habraken H, Petrovic M, Deveugele M, De Maeseneer J, Christiaens T. First benzodiazepine prescriptions: qualitative study of patients\u2019 perspectives. Can Fam Phys. 2007;53(7):1200\u20131.","journal-title":"Can Fam Phys"},{"issue":"6","key":"1580_CR31","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0277-9536(02)00133-8","volume":"56","author":"R Van Hulten","year":"2003","unstructured":"Van Hulten R, Bakker AB, Lodder AC, Teeuw KB, Bakker A, Leufkens HG. The impact of attitudes and beliefs on length of benzodiazepine use: a study among inexperienced and experienced benzodiazepine users. Soc Sci Med. 2003;56(6):1345\u201354.","journal-title":"Soc Sci Med"},{"key":"1580_CR32","unstructured":"Service Public F\u00e9d\u00e9ral. e-learning\u202f: benzolessconsult partie 1 & 2. Available from: https:\/\/www.health.belgium.be\/fr\/e-services\/e-learning"},{"key":"1580_CR33","unstructured":"Centre Belge d\u2019Informations Pharmacoth\u00e9rapeutique. E-Learning sevrage benzodiaz\u00e9pines. 2024. Available from: https:\/\/www.cbip.be\/fr\/nouvel-e-learning-sevrage-des-benzodiazepines\/"},{"key":"1580_CR34","doi-asserted-by":"publisher","first-page":"e5535","DOI":"10.7717\/peerj.5535","volume":"6","author":"A Mokhar","year":"2018","unstructured":"Mokhar A, Topp J, H\u00e4rter M, Schulz H, Kuhn S, Verthein U, et al. Patient-centered care interventions to reduce the inappropriate prescription and use of benzodiazepines and z-drugs: a systematic review. PeerJ. 2018;6: e5535.","journal-title":"PeerJ"},{"key":"1580_CR35","first-page":"BJGPO.2023.0034","volume":"19","author":"P Van Ngoc","year":"2023","unstructured":"Van Ngoc P, Ceuterick M, Belche JL, Scholtes B. Professionals\u2019 treatment goals for long-term benzodiazepine and Z-drugs management: a qualitative study. BJGP Open. 2023;19:BJGPO.2023.0034.","journal-title":"BJGP Open."},{"key":"1580_CR36","doi-asserted-by":"publisher","first-page":"111485","DOI":"10.1016\/j.jclinepi.2024.111485","volume":"174","author":"AM Manyara","year":"2024","unstructured":"Manyara AM, Purvis A, Ciani O, Collins GS, Taylor RS. Sample size in multistakeholder Delphi surveys: at what minimum sample size do replicability of results stabilize? J Clin Epidemiol. 2024;174: 111485.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1580_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/qshc.2004.011155","volume":"14","author":"S Michie","year":"2005","unstructured":"Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Safety Health Care. 2005;14(1):26\u201333.","journal-title":"Qual Safety Health Care"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01580-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-025-01580-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01580-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T19:03:18Z","timestamp":1750705398000},"score":1,"resource":{"primary":{"URL":"https:\/\/archpublichealth.biomedcentral.com\/articles\/10.1186\/s13690-025-01580-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1186\/s13690-025-01580-w","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was granted by the Ethics Committee (Hospital University Faculty Ethics Committee of Li\u00e8ge with approval number: 2021\/121 and Ethics Committee of the Faculty of Political and Social Sciences of Ghent University with reference number: EC- 2021\u201322). Before agreeing to participate in the e-study, the participants were provided with detailed information about the study and its objectives. They then provided voluntary and informed consent online. To maintain anonymity, all names and identifying information were omitted from the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participants who took part in the Policy Delphi were informed and agreed that the results would be published in a scientific journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}